Ethyl piperazine-2-carboxylate dihydrochloride, 95.0%, 100g

(R)-1-(2-Chlorophenyl)ethanol>98.0%(GC)5g

Round bottom flasks Clear glass, 250 ml, 19/26, 1 Piece

tri-magnesium citrate nonahydrate, Ph.Eur., USP, 100 g, plastic packaging.

2-Bromo-3-methoxyisonicotinaldehyde, 95%, 5g

5-Bromo-6-chloro-N-(2,4-dimethoxybenzyl)-N-(5-fluorothiazol-2-yl)pyridine-3-sulfonamide, 97%, 100mg

2-(chloromethyl)-4H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 5g

N,N-Dimethyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride, 97%, 5g

N4-Acetylcytosine>98.0%(T)5g

4-Amino-8-fluoro-2-methylquinoline, 97.0%, 1g

(3-(4-Methylpiperidine-1-carbonyl)phenyl)boronic acid, 95%, 5g

2-Bromo-1-(5-fluoro-2-methoxy-phenyl)-ethanone, 98.0%, 10g

2-Azaspiro[3.3]heptane oxalate(2:1), 95.0%, 1g